In software and life science technologies, many patent applicants eventually receive an office action rejecting their claimed invention as being directed to an abstract idea, natural law, or another judicial exception. This infamous rejection is typically referred to as an Alice rejection or a § 101 rejection in view of the relevant Supreme Court case and U.S. statute. In attempting to overcome such § 101 rejections, many patent applicants have complained that the USPTO’s subject matter eligibility (SME) test is applied inconsistently among different organizations at the USPTO, even amongst different examiners in the same technology art unit. A recent patent application filed by medical device company, Medtronic, provides a clear illustration of the confusion in applying the USPTO’s SME test. |